Time to reperfusion in acute myocardial infarction. It is time to reduce it!

被引:21
|
作者
Barbagelata, Alejandro
Perna, Eduardo R.
Clemmensen, Peter
Uretsky, Barry F.
Canella, Juan P. Cimbaro
Califf, Robert M.
Granger, Christopher B.
Adams, George L.
Merla, Ramanna
Birnbaum, Yochai
机构
[1] Univ Texas, Med Branch, Galveston, TX 77555 USA
[2] Inst Cardiol JF Cabral, Corrientes, Argentina
[3] Rigshosp, DK-2100 Copenhagen, Denmark
[4] Duke Univ, Clin Res Inst, Durham, NC USA
关键词
D O I
10.1016/j.jelectrocard.2007.01.007
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and Objectives: Mortality from ST-segment elevation myocardial infarction remains high, with most deaths occurring before hospital admission. Despite effective pre- and in-hospital reperfusion strategies becoming standard over the past 2 decades, time-to-admission and time-to-treatment remain prolonged. We reviewed temporal trends in these times in published clinical trials. Methods: All major randomized clinical trials reporting on reperfusion strategies for acute myocardial infarction published between 1993 and 2003 were evaluated. Strategies included pre- and in-hospital thrombolysis, primary percutaneous coronary intervention (pPCI) with or without transfer, and "facilitated' PCI. We generated overall estimates of time-to-admission, time-to-treatment, door-to-balloon (DTB), and door-to-needle (DTN) times and evaluated temporal trends in the length of time-to-admission and time-to-treatment. Results: In studies that evaluated only in-hospital thrombolysis, the time-to-admission was 149 +/- 45 minutes; the mean time-to-treatment was 181 +/- 29 minutes. In studies that considered only in-hospital pPCI (without transfer), the mean time-to-admission was 153 +/- 41 minutes; the mean time-to-treatment was 234 43 minutes. In studies that compared in-hospital pPCI with in-hospital thrombolytic therapy, the mean time-to-admission was 155 +/- 47 and 150 48 minutes, respectively. The DTN time was 65 10 minutes, whereas DTB time was 81 +/- 3 9 minutes. In other trials evaluating in-hospital thrombolysis and pPC1 with transfer to a referral center, the time-to-admission in subjects treated with thrombolysis (n 1345) was 127 +/- 32 minutes vs 131 +/- 36 minutes for pPCI (n = 1528). For in-hospital thrombolysis, time-to-treatment was 151 +/- 23 minutes vs 203 +/- 15 minutes for pPCI patients with transfer. The DTN time in the thrombolysis group was 44 28 minutes as compared with DTB time of 78 +/- 38 minutes in the pPCI group. Throughout the last decade, time-to-admission decreased significantly (P = .02) but time-to-treatment remained unchanged (P =.38) for patients undergoing thrombolysis. In the pPCI arm, time-to-admission remained unchanged (P = .11) but a insignificant trend toward reduction was demonstrated in time-to-treatment (P = .11). Conclusion: Time-to-admission and time-to-treatment for ST-segment: elevation myocardial infarction are still prolonged. Resources should be directed to early recognition of the acute myocardial infarction, improved utilization of emergency services for transportation, and prehospital diagnosis and triaging. Ambulances equipped with wireless capability to transmit electrocardiograms to the on-call cardiologist seem to be promising tools to achieve earlier diagnosis and triaging with high diagnostic sensitivity and specificity. (C) 2007 Published by Elsevier Inc.
引用
收藏
页码:257 / 264
页数:8
相关论文
共 50 条
  • [1] Perspective: Reperfusion therapy in acute myocardial infarction.
    Lange, RA
    Hillis, LD
    NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (13): : 954 - 955
  • [2] Troponin t elevation at baseline and failure of reperfusion after acute myocardial infarction. An on-time substudy
    Rasoul, S
    De Boer, MJ
    Ernst, N
    Slingerland, RJ
    Kolkman, E
    Suryapranata, H
    Zijlstra, F
    van 't Hof, AWJ
    EUROPEAN HEART JOURNAL, 2004, 25 : 193 - 193
  • [3] A predictive instrument for reperfusion therapy for acute myocardial infarction.
    Kent, DM
    Ruthazer, R
    Beshansky, JR
    Griffith, JL
    Grines, CL
    Aversano, T
    Zalenski, R
    Selker, HP
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2003, 18 : 225 - 225
  • [4] Reperfusion in acute myocardial infarction. Thrombolysis or balloon dilatation?
    Zeymer, U
    Neuhaus, KL
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1997, 122 (36) : 1081 - 1085
  • [5] Impact of plaque characteristics on myocardial tissue reperfusion in acute myocardial infarction.
    Kawano, S
    Ito, H
    Iwakura, K
    Okamura, A
    Kurotobi, T
    Date, M
    Inoue, K
    Hiramoto, Y
    Hanibuchi, N
    Hayashi, N
    Hashimoto, T
    Nagai, H
    Takeda, M
    Fujii, K
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (03) : 232A - 233A
  • [6] Complications of immediate reperfusion therapy during acute myocardial infarction.
    Noga, CM
    Stewart, RE
    Ratliff, NB
    LABORATORY INVESTIGATION, 1999, 79 (01) : 38A - 38A
  • [7] Drug-coated balloons for acute myocardial infarction. Ready for prime time?
    Alfonso, Fernando
    Elgendy, Islam Y.
    Cortese, Bernardo
    EUROINTERVENTION, 2020, 15 (17) : 1479 - 1482
  • [8] Heart failure complicating acute myocardial infarction. Does the time of presentation matter?
    Consuegra-Sanchez, Luciano
    Jaulent-Huertas, Leticia
    Vicente-Gilabert, Marta
    Escudero-Garcia, German
    Diaz-Pastor, Angela
    Galcera-Tomas, Jose
    Melgarejo-Moreno, Antonio
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 204 : 48 - 50
  • [9] Variation in Glycemia in Patients Hospitalized With Acute Myocardial Infarction. Is It Time for Glucose Monitoring?
    Kosiborod, Mikhail
    REVISTA ESPANOLA DE CARDIOLOGIA, 2009, 62 (10): : 1092 - 1094
  • [10] Is it possible to reduce reperfusion injury in acute myocardial infarction?
    Podolecka, Ewa
    KARDIOLOGIA POLSKA, 2010, 68 (12) : 1385 - 1390